Testing effectiveness (Phase 2)Ended earlyNCT01562899
What this trial is testing
MEK162 and AMG 479 in Patients With Selected Solid Tumors
Who this might be right for
Metastatic Pancreatic AdenocarcinomaBRAF Mutated Melanoma
Pfizer 77
Showing 20 of 0 results